Formulation and <i>In Vitro</i> Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension

<table class="table-group" id="tab16"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td align="left">Name</td><td align="center">Weight variation (%)</td><td align="center">Hardness  (kg/cm<sup>2</sup>)</td><td align="center">Thickness (mm)</td><td align="center">Friability (%)</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td align="left">Bilayer tablet </td><td align="center">0.54</td><td align="center">6.5</td><td align="center">5.36</td><td align="center">0.48</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Journal of Drug Delivery

tab16

Table 16

Table 16: Formulation and <i>In Vitro</i> Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension 

Table 16 | Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension 